Science
Mechanism of Action
Harpagoside acts as a significant anti-inflammatory agent by inhibiting key pro-inflammatory mediators. It achieves this by suppressing the activity of cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, both crucial in the body's inflammatory cascade. Furthermore, Harpagoside modulates cytokine expression and suppresses lipopolysaccharide-induced iNOS and COX-2 expression by inhibiting NF-κB activation, thereby reducing cellular inflammatory signals.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
No specific data is available to indicate Harpagoside is commonly 'dusted' in formulations, nor are there established dusting thresholds for its topical application.
The Formula
Formulation
Stability
Harpagoside is readily soluble in water, methanol, ethanol, and other polar organic solvents. Formulations containing Harpagoside are generally stable within a skin-friendly pH range of 4.0 to 6.0, with stability observed over at least one month at pH 5.5–5.7 and up to a 6-month period in various formulations.
Safety
Safety Profile
Harpagoside has not been explicitly reviewed by the Cosmetic Ingredient Review (CIR), SCCS, or FDA for its use in skincare. While Devil's Claw (its source) is considered possibly safe for oral intake for up to 12 weeks, there is insufficient reliable information regarding its safety or potential side effects when applied topically to the skin. Oral intake of Devil's Claw may induce allergic skin reactions, suggesting a potential for sensitization, though specific topical data is limited.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Harpagoside exhibits a compelling anti-inflammatory mechanism supported by in vitro and oral studies, definitive topical clinical data on its effective concentration and comprehensive safety profile are currently limited, necessitating further research for its precise application in skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources